Changes in High-Density Lipoprotein Cholesterol Levels in Relation to Coffee Consumption Among Taiwanese Adults

References

• Marjani AA. Review on HDL-cholesterol alterations in metabolic syndrome. J Biol Sci. 2013;13(8):679–684. doi:10.3923/jbs.2013.679.684
   Google Scholar
• Haslam DE, Peloso GM, Herman MA, et al. Beverage consumption and longitudinal changes in lipoprotein concentrations and incident dyslipidemia in US adults: the Framingham heart study. J Am Heart Assoc. 2020;9(5):e014083. doi:10.1161/JAHA.119.014083
   Web of Science ®Google Scholar
• Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40(1):195–211.
   PubMed Web of Science ®Google Scholar
• Ventura HO, Lavie CJ, Mehra MR. HDL and heart failure regulation: still breathing but exhausted. J Am Coll Cardiol. 2019;187–189.
   Web of Science ®Google Scholar
• Steyn K, Fourie J, Benade A, et al. Factors associated with high density lipoprotein cholesterol in a population with high high density lipoprotein cholesterol levels. Arteriosclerosis. 1989;9(3):390–397. doi:10.1161/01.ATV.9.3.390
   Google Scholar
• Corrêa TA, Rogero MM, Mioto BM, et al. filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial. Nutrition. 2013;29(7–8):977–981. doi:10.1016/j.nut.2013.01.003
   PubMed Web of Science ®Google Scholar
• Zargar A, Auttapibarn C, Hong SH, Larson TJ, Hayworth KH, Ito MK. The effect of acute café latte ingestion on fasting serum lipid levels in healthy individuals. J Clin Lipidol. 2013;7(2):165–168. doi:10.1016/j.jacl.2012.11.001
   Web of Science ®Google Scholar
• Salonen JT, Happonen P, Salonen R, et al. Interdependence of associations of physical activity, smoking, and alcohol and coffee consumption with serum high-density lipoprotein and non-high-density lipoprotein cholesterol—a population study in eastern Finland. Prev Med. 1987;16(5):647–658. doi:10.1016/0091-7435(87)90048-X
   Web of Science ®Google Scholar
• Shang F, Li X, Jiang X. Coffee consumption and risk of the metabolic syndrome: a meta-analysis. Diabetes Metab. 2016;42(2):80–87. doi:10.1016/j.diabet.2015.09.001
   Web of Science ®Google Scholar
• Grosso G, Stepaniak U, Micek A, et al. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr. 2015;54(7):1129–1137. doi:10.1007/s00394-014-0789-6
   Web of Science ®Google Scholar
• Marventano S, Salomone F, Godos J, et al. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clin nutr. 2016;35(6):1269–1281. doi:10.1016/j.clnu.2016.03.012
   PubMed Web of Science ®Google Scholar
• Choi Y, Chang Y, Ryu S, et al. Coffee consumption and coronary artery calcium in young and middle-aged asymptomatic adults. Heart. 2015;101(9):686–691. doi:10.1136/heartjnl-2014-306663
   Web of Science ®Google Scholar
• Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366:1891–1904. doi:10.1056/NEJMoa1112010
   PubMed Web of Science ®Google Scholar
• Kokubo Y, Iso H, Saito I, et al. The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: the Japan public health center-based study cohort. Stroke. 2013;44(5):1369–1374. doi:10.1161/STROKEAHA.111.677500
   Web of Science ®Google Scholar
• Fung K, Biasiolli L, Hann E, et al. 9 Effect of coffee consumption on arterial stiffness from UK biobank imaging study. British Cardiac Society. 2019;A8–A10.
   Google Scholar
• Wang Y, Tuomilehto J, Jousilahti P, et al. Coffee consumption and the risk of heart failure in Finnish men and women. Heart. 2011;97(1):44–48. doi:10.1136/hrt.2010.206045
   Web of Science ®Google Scholar
• Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153(4):353–362. doi:10.1093/aje/153.4.353
   PubMed Web of Science ®Google Scholar
• Ricketts M-L. Does Coffee Raise Cholesterol? Taylor & Francis; 2007.
   Google Scholar
• Chang H-C, Liang J, Hsu H-C, Lin S-K, Chang T-H, Liu S-H. Regular exercise and the trajectory of health-related quality of life among Taiwanese adults: a cohort study analysis 2006–2014. BMC Public Health. 2019;19(1):1352. doi:10.1186/s12889-019-7662-8
   Web of Science ®Google Scholar
• Chang H, Kung Y, Hsieh C, Hsiung L, Chang S, Chen T. Biological risk factors relevant to chronic disease in three ethnic groups in Taiwan: results from Li-Shin outreaching neighborhood screening (Lions A1). Ethn Dis. 2008;18(2):228.
   Web of Science ®Google Scholar
• Chang H-C, Hsieh C-F, Lin Y-C, et al. Does coffee drinking have beneficial effects on bone health of Taiwanese adults? A longitudinal study. BMC Public Health. 2018;18(1):1273.
   Web of Science ®Google Scholar
• Fried RE, Levine DM, Kwiterovich PO, et al. The effect of filtered-coffee consumption on plasma lipid levels: results of a randomized clinical trial. JAMA. 1992;267(6):811–815. doi:10.1001/jama.1992.03480060057030
   Web of Science ®Google Scholar
• Kempf K, Herder C, Erlund I, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 2010;91(4):950–957. doi:10.3945/ajcn.2009.28548
   PubMed Web of Science ®Google Scholar
• Miyake Y, Kono S, Nishiwaki M, et al. Relationship of coffee consumption with serum lipids and lipoproteins in Japanese men. Ann Epidemiol. 1999;9(2):121–126. doi:10.1016/S1047-2797(98)00051-9
   Web of Science ®Google Scholar
• Cai L, Ma D, Zhang Y, Liu Z, Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2012;66(8):872–877. doi:10.1038/ejcn.2012.68
   PubMed Web of Science ®Google Scholar
• Cheung RJ, Gupta EK, Ito MK. Acute coffee ingestion does not affect LDL cholesterol level. Ann Pharmacother. 2005;39(7–8):1209–1213. doi:10.1345/aph.1G005
   Web of Science ®Google Scholar
• Brunner FJ, Waldeyer C, Ojeda F, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the multinational cardiovascular risk consortium. Lancet. 2019;394(10215):2173–2183. doi:10.1016/S0140-6736(19)32519-X
   PubMed Web of Science ®Google Scholar